Sign in

CareALS+

@neurodegeneration.bsky.social
19 followers 2 following 831 posts

Follow to get regular updates on ALS+, Neurodegenerative Biology, Aging and Medicine Research | Education | Awareness | Importance | Medicine | Human Health | Neurons | Life | Nature #neurodegeneration #aging #breakthrough #clinicaltrial

PostsRepliesMedia
CareALS+ @neurodegeneration.bsky.social · 06/06/2026
Short RNA chaperones promote aggregation-resistant TDP-43 conformers to mitigate neurodegeneration | Science www.science.org/doi/10.1126/... --> One step closer in search of a cure to ALS. #ALS #neurodegeneration #Cure
science.org
Short RNA chaperones promote aggregation-resistant TDP-43 conformers to mitigate neurodegeneration
Aberrant aggregation of the prion-like RNA binding protein TDP-43 drives several fatal neurodegenerative proteinopathies, including amyotrophic lateral sclerosis (ALS). In this work, we define how sho...
010
CareALS+ @neurodegeneration.bsky.social · 16/12/2025
[BioRxiv] Retrotransposon Activation in the Aged and Alzheimer's Disease Brain Examined by Nanopore Long-read DNA Sequencing doi.org/10.64898/2025.12.12.693943 #neurodegeneration #biorxiv #Alzheimers
doi.org
BioRxiv Article
000
CareALS+ @neurodegeneration.bsky.social · 16/12/2025
[BioRxiv] RBProximity-CLIP Enables Subcellular Mapping of RNA-Binding Protein Interactions at Nucleotide Resolution doi.org/10.64898/2025.12.12.693770 #neurodegeneration #biorxiv #RNAbindingprotein
doi.org
BioRxiv Article
000
CareALS+ @neurodegeneration.bsky.social · 16/12/2025
[BioRxiv] Native, full-length, refolding-assisted purification of TDP-43 compatible with BSL-2 safety regulations doi.org/10.64898/2025.12.10.693404 #neurodegeneration #biorxiv #Dementia #ALS #RNAbindingprotein
doi.org
BioRxiv Article
000
CareALS+ @neurodegeneration.bsky.social · 16/12/2025
[BioRxiv] Degraded sensory coding in a mouse model of Scn2a-related disorder and its rescue by CRISPRa gene activation doi.org/10.64898/2025.12.13.694145 #neurodegeneration #biorxiv #biomarker #CRISPR
doi.org
BioRxiv Article
000
CareALS+ @neurodegeneration.bsky.social · 16/12/2025
[BioRxiv] Striatal pathology in Spinocerebellar Ataxia Type 1 mice: A comparative study with Huntingtons disease doi.org/10.64898/2025.12.11.693749 #neurodegeneration #biorxiv #Neurodegeneration
doi.org
BioRxiv Article
000
CareALS+ @neurodegeneration.bsky.social · 16/12/2025
[BioRxiv] Conserved phenotype and function of human brain border-associated macrophages in iPSC-derived models doi.org/10.64898/2025.12.11.693582 #neurodegeneration #biorxiv #amyloidbeta #amyloid
doi.org
BioRxiv Article
000
CareALS+ @neurodegeneration.bsky.social · 16/12/2025
[BioRxiv] RNA modulates FUS condensate assembly, dynamics, and aggregation through diverse molecular contacts doi.org/10.64898/2025.12.13.694118 #neurodegeneration #biorxiv #phaseseparation #RNAbindingprotein #aggregate
doi.org
BioRxiv Article
000
CareALS+ @neurodegeneration.bsky.social · 16/12/2025
[BioRxiv] Temporal Dynamics of High-Frequency Oscillations in Alzheimer's Disease: A Longitudinal Study in hAPP-J20 Mice doi.org/10.64898/2025.12.10.693578 #neurodegeneration #biorxiv #amyloid #Alzheimers
doi.org
BioRxiv Article
000
CareALS+ @neurodegeneration.bsky.social · 16/12/2025
[BioRxiv] Neuronal APOE4 reduction with an APOE-I3-targeting ASO protects against neurodegeneration and neuroinflammation in an Alzheimer's disease mouse model doi.org/10.64898/2025.12.10.693468 #neurodegeneration #biorxiv #antisenseoligonucleotides #Alzheimers #ASO #Neurodegeneration
doi.org
BioRxiv Article
000
CareALS+ @neurodegeneration.bsky.social · 16/12/2025
[BioRxiv] Tau oligomer heterogeneity and associated protein profile in slowly versus rapidly progressive Alzheimer's disease doi.org/10.64898/2025.12.10.693456 #neurodegeneration #biorxiv #Alzheimers
doi.org
BioRxiv Article
000
CareALS+ @neurodegeneration.bsky.social · 16/12/2025
[BioRxiv] Tracking gene expression of single mitochondria in live neurons using nanotweezers doi.org/10.64898/2025.12.10.693488 #neurodegeneration #biorxiv #Neurodegeneration
doi.org
BioRxiv Article
000
CareALS+ @neurodegeneration.bsky.social · 16/12/2025
[BioRxiv] Reduction of Aβ25-35-Induced Cognitive Impairments in C57BL/6 Mice Through Focused Ultrasound Thermal-Cycling Stimulation doi.org/10.64898/2025.12.10.693347 #neurodegeneration #biorxiv #amyloid #oxidativestress
doi.org
BioRxiv Article
000
CareALS+ @neurodegeneration.bsky.social · 16/12/2025
[BioRxiv] Cryo-EM structures of anti Z-DNA antibodies in complex with antigen reveal distinct recognition modes of a left-handed geometry doi.org/10.64898/2025.12.12.693871 #neurodegeneration #biorxiv #Alzheimers
doi.org
BioRxiv Article
000
CareALS+ @neurodegeneration.bsky.social · 16/12/2025
[BioRxiv] Reconstructing developmental and disease progression with sample-level embeddings doi.org/10.64898/2025.12.10.693462 #neurodegeneration #biorxiv #Neurodegeneration
doi.org
BioRxiv Article
000
CareALS+ @neurodegeneration.bsky.social · 16/12/2025
[BioRxiv] Mapping the circulating proteome across neurodegeneration: A harmonized, consortium-scale framework for uncovering molecular pathophysiology doi.org/10.64898/2025.12.09.693329 #neurodegeneration #biorxiv #biomarker #Neurodegeneration #Dementia #ALS
doi.org
BioRxiv Article
000
CareALS+ @neurodegeneration.bsky.social · 16/12/2025
[BioRxiv] Motor System Oligodendroglia Atlas Reveals Activation States Associated with Region-Specific Vulnerability in ALS doi.org/10.64898/2025.12.09.693234 #neurodegeneration #biorxiv #biomarker #ALS
doi.org
BioRxiv Article
000
CareALS+ @neurodegeneration.bsky.social · 16/12/2025
[BioRxiv] Phase Behavior of TDP-43 and hnRNP H1: From Soluble and Aggregated States to Liquid-Like Droplets doi.org/10.1101/2025.11.12.687994 #neurodegeneration #biorxiv #phaseseparation #aggregate
doi.org
BioRxiv Article
000
CareALS+ @neurodegeneration.bsky.social · 16/12/2025
[BioRxiv] Shift in motor-state equilibrium explains gait therapy effects of apomorphine in experimental Parkinsonism doi.org/10.1101/2025.09.07.673890 #neurodegeneration #biorxiv #Parkinsons
doi.org
BioRxiv Article
000
CareALS+ @neurodegeneration.bsky.social · 16/12/2025
Cross-domain Fisher criterion for remote therapeutic efficacy assessment of Parkinson's disease via speech recognition. pubmed.ncbi.nlm.nih.gov/41396313 #neurodegeneration #pubmed #Parkinsons
pubmed.ncbi.nlm.nih.gov
Cross-domain Fisher criterion for remote therapeutic efficacy assessment of Parkinson's disease via speech recognition - PubMed
To address the limitation that prevailing cross-domain Parkinson's disease (PD) speech recognition methods mitigate small-sample issues via distribution matching while disregarding substantial feature
000
CareALS+ @neurodegeneration.bsky.social · 16/12/2025
Insight into the Neuroprotective Mechanisms of Resveratrol: Inhibition of Alpha-Synuclein Fibrillation and its Role in Mitigating Toxicity. pubmed.ncbi.nlm.nih.gov/41396370 #neurodegeneration #pubmed #neuroprotective
pubmed.ncbi.nlm.nih.gov
Insight into the Neuroprotective Mechanisms of Resveratrol: Inhibition of Alpha-Synuclein Fibrillation and its Role in Mitigating Toxicity - PubMed
Insight into the Neuroprotective Mechanisms of Resveratrol: Inhibition of Alpha-Synuclein Fibrillation and its Role in Mitigating Toxicity
000
CareALS+ @neurodegeneration.bsky.social · 16/12/2025
Unraveling the potential of gasotransmitters as neurogenic and neuroprotective molecules: focus on Alzheimer's and Parkinson's diseases. pubmed.ncbi.nlm.nih.gov/41396689 #neurodegeneration #pubmed #Alzheimers #neuroprotective #Parkinsons
pubmed.ncbi.nlm.nih.gov
Unraveling the potential of gasotransmitters as neurogenic and neuroprotective molecules: focus on Alzheimer's and Parkinson's diseases - PubMed
Alzheimer's disease and Parkinson's disease are the two most prevalent neurodegenerative disorders worldwide, both characterized by progressive neuronal loss. Despite distinct pathophysiological featu
000
CareALS+ @neurodegeneration.bsky.social · 16/12/2025
What can vowel acoustics reveal about the communicative participation of people living with ALS? pubmed.ncbi.nlm.nih.gov/41396714 #neurodegeneration #pubmed #ALS
pubmed.ncbi.nlm.nih.gov
What can vowel acoustics reveal about the communicative participation of people living with ALS? - PubMed
<span><i>Objective</i>: Bulbar dysfunction often diminishes the accuracy and speed of the tongue, lip, and jaw movements necessary for speech production. Vowel acoustic features derived from speech re
000
CareALS+ @neurodegeneration.bsky.social · 16/12/2025
Investigating the Effectiveness of Haptic Resistive Force Feedback to Improve Tremors in Parkinson's Disease: A Training Impact Study. pubmed.ncbi.nlm.nih.gov/41396751 #neurodegeneration #pubmed #Parkinsons
pubmed.ncbi.nlm.nih.gov
Investigating the Effectiveness of Haptic Resistive Force Feedback to Improve Tremors in Parkinson's Disease: A Training Impact Study - PubMed
The goal of this study was to investigate the effectiveness of haptic resistive force feedback in improving the upper limb tremors in Parkinson's Disease (PD) during a button push task. We developed a
000
CareALS+ @neurodegeneration.bsky.social · 16/12/2025
Abnormal Large-Scale Dynamic Brain Networks in Parkinson's Disease with Cognitive Impairment: Insights from EEG Co-Activation Patterns. pubmed.ncbi.nlm.nih.gov/41396773 #neurodegeneration #pubmed #Parkinsons
pubmed.ncbi.nlm.nih.gov
Abnormal Large-Scale Dynamic Brain Networks in Parkinson's Disease with Cognitive Impairment: Insights from EEG Co-Activation Patterns - PubMed
This study investigated the large-scale dynamic brain network mechanisms underlying cognitive decline in Parkinson's disease (PD) by integrating high-density Electroencephalography (EEG) signal source
000
CareALS+ @neurodegeneration.bsky.social · 16/12/2025
Physical Exercise and Survival in Parkinson's Disease: A Cohort Study. pubmed.ncbi.nlm.nih.gov/41396816 #neurodegeneration #pubmed #Parkinsons
pubmed.ncbi.nlm.nih.gov
Physical Exercise and Survival in Parkinson's Disease: A Cohort Study - PubMed
To estimate the overall survival rate, disease stage, age of people with Parkinson's disease, and time since diagnosis and in relation to physical exercise. Retrospective-prospective longitudinal obse
000
CareALS+ @neurodegeneration.bsky.social · 16/12/2025
Pioglitazone attenuates complement-mediated microglial synaptic engulfment in an Alzheimer's disease model. pubmed.ncbi.nlm.nih.gov/41396874 #neurodegeneration #pubmed #Alzheimers
pubmed.ncbi.nlm.nih.gov
Pioglitazone attenuates complement-mediated microglial synaptic engulfment in an Alzheimer's disease model - PubMed
Synaptic loss is an early hallmark of Alzheimer's disease (AD), predominantly driven by aberrant microglial reactivity. Pioglitazone, a peroxisome proliferator-activated receptor-γ (PPAR-γ) agonist wi
000
CareALS+ @neurodegeneration.bsky.social · 16/12/2025
A mixed-methods study to explore the modifiable aspects of treatment burden in Parkinson's disease and develop recommendations for improvement. pubmed.ncbi.nlm.nih.gov/41397020 #neurodegeneration #pubmed #Parkinsons
pubmed.ncbi.nlm.nih.gov
A mixed-methods study to explore the modifiable aspects of treatment burden in Parkinson's disease and develop recommendations for improvement - PubMed
Treatment burden is common amongst PwP and caregivers and could be identified in clinical practice using the MTBQ. There is a need for change at individual provider and system levels to recognise and
000
CareALS+ @neurodegeneration.bsky.social · 16/12/2025
Destabilization of Helix III Initiates Early Serum Amyloid A Misfolding by Exposing Its Amyloidogenic Core. pubmed.ncbi.nlm.nih.gov/41397263 #neurodegeneration #pubmed #amyloid
pubmed.ncbi.nlm.nih.gov
Destabilization of Helix III Initiates Early Serum Amyloid A Misfolding by Exposing Its Amyloidogenic Core - PubMed
Serum amyloid A (SAA) is the principal precursor of AA amyloidosis, yet the early molecular steps that trigger its pathological misfolding remain unclear. Here, we combine harmonic linear discriminant
000
CareALS+ @neurodegeneration.bsky.social · 16/12/2025
Investigating the therapeutic mechanisms of dental pulp stem cells in Parkinson's disease: A bioinformatics-based multi-omics analysis. pubmed.ncbi.nlm.nih.gov/41397323 #neurodegeneration #pubmed #Parkinsons
pubmed.ncbi.nlm.nih.gov
Investigating the therapeutic mechanisms of dental pulp stem cells in Parkinson's disease: A bioinformatics-based multi-omics analysis - PubMed
Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by dopaminergic neuron loss and α-synuclein aggregation. Dental pulp stem cells (DPSCs) have emerged as a promising t
000
CareALS+ @neurodegeneration.bsky.social · 12/12/2025
[BioRxiv] Spatiotemporal Network Dynamics Reveal Alzheimer's Disease Progression doi.org/10.64898/2025.12.09.692653 #neurodegeneration #biorxiv #Dementia #biomarker #Alzheimers
doi.org
BioRxiv Article
000
CareALS+ @neurodegeneration.bsky.social · 12/12/2025
[BioRxiv] PKC-dependent MYRF dysregulation links Aβ pathology to oligodendrocyte, myelin and cognitive alterations in Alzheimer's disease doi.org/10.64898/2025.12.09.693299 #neurodegeneration #biorxiv #amyloid #synapticdysfunction #Alzheimers
doi.org
BioRxiv Article
000
CareALS+ @neurodegeneration.bsky.social · 12/12/2025
[BioRxiv] Soluble epoxide hydrolase upregulation in Alzheimer's disease promotes blood-brain barrier dysfunction doi.org/10.64898/2025.12.09.692941 #neurodegeneration #biorxiv #amyloid #oxidativestress #Alzheimers
doi.org
BioRxiv Article
000
CareALS+ @neurodegeneration.bsky.social · 12/12/2025
[BioRxiv] Ischemic injury triggers a protective microglial phenotype in models of Aβ pathology doi.org/10.64898/2025.12.09.692939 #neurodegeneration #biorxiv #amyloid #neuroprotective
doi.org
BioRxiv Article
000
CareALS+ @neurodegeneration.bsky.social · 12/12/2025
[BioRxiv] The circadian clock regulates scavenging of fluid-borne substrates by brain border-associated macrophages doi.org/10.64898/2025.12.08.693074 #neurodegeneration #biorxiv #amyloid #amyloidbeta #Alzheimers
doi.org
BioRxiv Article
010
CareALS+ @neurodegeneration.bsky.social · 12/12/2025
[BioRxiv] Plasmalogen-Independent Neuroprotection: Synthetic alkyl ether lipids activate signaling to mitigate neuroinflammation and enhance cognitive function doi.org/10.64898/2025.12.08.693101 #neurodegeneration #biorxiv #neuroprotective #Alzheimers
doi.org
BioRxiv Article
000
CareALS+ @neurodegeneration.bsky.social · 12/12/2025
[BioRxiv] Epoxyazadiradione ameliorates Parkinson's disease by upregulating heat shock factor 1 and protein degradation pathways in mice. doi.org/10.64898/2025.12.08.692835 #neurodegeneration #biorxiv #Parkinsons
doi.org
BioRxiv Article
000
CareALS+ @neurodegeneration.bsky.social · 12/12/2025
[BioRxiv] IsoformSwitchAnalyzeR v2: Analysis of Functional Isoform Changes in Long-read and Single-cell Sequencing Data doi.org/10.64898/2025.12.08.693027 #neurodegeneration #biorxiv #Alzheimers
doi.org
BioRxiv Article
000
CareALS+ @neurodegeneration.bsky.social · 12/12/2025
[BioRxiv] The Research Landscape of Dynamic Functional Connectivity in Parkinson's Disease: Systematic Review and Interactive Tool doi.org/10.64898/2025.12.08.692999 #neurodegeneration #biorxiv #Parkinsons
doi.org
BioRxiv Article
000
CareALS+ @neurodegeneration.bsky.social · 12/12/2025
[BioRxiv] Therapeutic modulation of the calpastatin/calpain pathway restores calpain-mediated synaptic proteolysis and preserves motor neurons survival and function in C9orf72 ALS doi.org/10.64898/2025.12.08.692907 #neurodegeneration #biorxiv #C9ORF72 #ALS #Neurodegeneration
doi.org
BioRxiv Article
000
CareALS+ @neurodegeneration.bsky.social · 12/12/2025
[BioRxiv] PLD1-Dependent Regulation of Synaptic Integrity: Implications for Cognitive Resilience and Alzheimer's Disease Pathogenesis doi.org/10.64898/2025.12.08.692971 #neurodegeneration #biorxiv #Dementia #Alzheimers
doi.org
BioRxiv Article
000
CareALS+ @neurodegeneration.bsky.social · 12/12/2025
[BioRxiv] ALS/FTD-associated TDP-43 mutations promote fragility of genes governing excitatory neurotransmission via topoisomerase IIβ impairment doi.org/10.64898/2025.12.08.693088 #neurodegeneration #biorxiv #ALS #RNAbindingprotein #Dementia
doi.org
BioRxiv Article
000
CareALS+ @neurodegeneration.bsky.social · 12/12/2025
[BioRxiv] Age-specific Aβ-Tau interactions underlie spatial memory deficits in an APP/PS1 amyloidosis model doi.org/10.64898/2025.12.06.689974 #neurodegeneration #biorxiv #amyloid #amyloidbeta #Alzheimers
doi.org
BioRxiv Article
000
CareALS+ @neurodegeneration.bsky.social · 12/12/2025
[BioRxiv] Restoring Amyloid Clearance via Astrocytes: Z17 Is a Selective Inhibitor of CHI3L1 in Alzheimers Disease doi.org/10.64898/2025.12.07.692801 #neurodegeneration #biorxiv #amyloid
doi.org
BioRxiv Article
000
CareALS+ @neurodegeneration.bsky.social · 12/12/2025
[BioRxiv] Neuronal PARIS-STAT3 axis drives tau pathology and glial activation in Alzheimers disease doi.org/10.64898/2025.12.06.692741 #neurodegeneration #biorxiv #amyloid #Neurodegeneration
doi.org
BioRxiv Article
000
CareALS+ @neurodegeneration.bsky.social · 12/12/2025
[BioRxiv] Intranigral injection of Alpha-Synuclein pre-formed fibrils leads to BBB compromise and Bilateral Dopaminergic Neurodegeneration in A53T Alpha-Synuclein transgenic mice. doi.org/10.1101/2025.11.26.690780 #neurodegeneration #biorxiv #Parkinsons #Neurodegeneration
doi.org
BioRxiv Article
000
CareALS+ @neurodegeneration.bsky.social · 12/12/2025
[BioRxiv] A comparative transcriptomic analysis of mouse demyelination models and Multiple Sclerosis lesions doi.org/10.1101/2025.03.24.645058 #neurodegeneration #biorxiv #Neurodegeneration
doi.org
BioRxiv Article
000
CareALS+ @neurodegeneration.bsky.social · 12/12/2025
[BioRxiv] Stick of Sticks: Structural Features of the Amyloidogenic Peptide-DNA Complex doi.org/10.1101/2024.11.05.622117 #neurodegeneration #biorxiv #amyloid
doi.org
BioRxiv Article
000
CareALS+ @neurodegeneration.bsky.social · 12/12/2025
Discontinuation of Tafamidis in Wild-Type Transthyretin Amyloid Cardiomyopathy Patients. pubmed.ncbi.nlm.nih.gov/41377626 #neurodegeneration #pubmed #amyloid
pubmed.ncbi.nlm.nih.gov
Discontinuation of Tafamidis in Wild-Type Transthyretin Amyloid Cardiomyopathy Patients - PubMed
The period from tafamidis discontinuation to death was shorter in ATTRwt-CM patients hospitalized for non-cardiovascular diseases. Discussions of the right period for discontinuation are needed.
000
CareALS+ @neurodegeneration.bsky.social · 12/12/2025
Speech pause and speech rate for evaluating Alzheimer's and mild cognitive impairment: A meta-analysis. pubmed.ncbi.nlm.nih.gov/41378466 #neurodegeneration #pubmed #Alzheimers
pubmed.ncbi.nlm.nih.gov
Speech pause and speech rate for evaluating Alzheimer's and mild cognitive impairment: A meta-analysis - PubMed
Of the many ways that speech can be objectified, pauses appear particularly important for understanding cognition in AD. Pause analysis has the benefit of being face valid, interpretable in ratio form
000